NPI: 1558524512 · FAIRFIELD, CT 06824 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 07/09/2008
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 07/09/2008 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 21,613 | $360K |
| 2019 | 19,272 | $177K |
| 2020 | 12,467 | $108K |
| 2021 | 12,710 | $127K |
| 2022 | 7,699 | $64K |
| 2023 | 5,873 | $213K |
| 2024 | 1,346 | $19K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 25,704 | 2,411 | $445K |
| 82607 | 1,333 | 1,148 | $192K | |
| 82728 | 1,628 | 1,383 | $160K | |
| 82746 | 1,342 | 1,151 | $126K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 28,128 | 1,409 | $31K |
| 82108 | 113 | 91 | $28K | |
| 83540 | 1,662 | 1,392 | $27K | |
| 83550 | 1,459 | 1,216 | $16K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 392 | 226 | $13K |
| 83970 | 1,670 | 1,402 | $11K | |
| A4657 | Syringe, with or without needle, each | 1,695 | 1,491 | $8K |
| J1270 | Injection, doxercalciferol, 1 mcg | 9,495 | 857 | $5K |
| J1756 | Injection, iron sucrose, 1 mg | 2,906 | 851 | $5K |
| 85041 | 1,537 | 1,313 | $339.71 | |
| 85048 | 1,535 | 1,312 | $286.93 | |
| 90662 | 32 | 30 | $0.00 | |
| 90670 | 17 | 12 | $0.00 | |
| 85045 | 13 | 12 | $0.00 | |
| 90674 | 32 | 25 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 230 | 123 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 43 | 38 | $0.00 |
| 87340 | 14 | 12 | $0.00 |